Bibliography
- Shukla D, Chakraborty S, Singh S, Mishra B. Pastillation: a novel technology for development of oral lipid based multiparticulate controlled release formulation. Powder Technol 2011;9:65-72
- Shukla D, Chakraborty S, Singh S, Mishra B. Lipid based oral multiparticulate formulations – Advantages, technological advances and industrial applications. Expert Opin Drug Deliv 2011;8:207-24
- Skloot G. Nocturnal asthma: mechanisms and management. Mt Sinai J Med 2002;69:140-7
- Robertson CE, Rubinfeld AR, Bowej G. Deaths from asthma in Victoria: a 12-month study. Med J Aust 1990;152:511-17
- Turner-Warwick M. Epdemiology of nocturnal asthma. Am J Med 1988;85(Suppl 1B):6-8
- Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev 2002;54:53-77
- Sawada T, Kondo H, Nakashima H, Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int J Pharm 2004;280:103-11
- Rubinstein A, Tirosh B, Baluom M, The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J Control Release 1997;46:59-73
- Sawada T, Sako K, Yoshihara K, Timed release formulation to avoid drug–drug interaction between diltiazem and midazolam. J Pharm Sci 2003;92:790-7
- Parker JO, Fung HL, Rugginello D, Stone JA. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation 1983;68:1074-80
- Flaherty JT. Nitrate tolerance. A review of the evidence. Drugs 1989;37:523-50
- Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm Biopharm 2007;65:85-93
- Sharma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006;313:150-8
- Tekade AR, Gattani SG. Dual cross-linked pulsatile beads for chronotherapy of asthma: development and evaluation. Drug Deliv 2010;17:581-6
- Tekade AR, Gattani SG. Development and evaluation of pulsatile drug delivery system using novel polymer. Pharm Dev Technol 2009;14:380-7
- Shukla D, Chakraborty S, Singh S, Mishra B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2009;10:2343-56
- Gutowski WThermodynamics of adhesion. In: Lee L-H, editor. Fundamentals of adhesion. Plenum Publishing Corp.; New York: 1991
- Kamila MM, Mondal N, Ghosh LK, Gupta BKMultiunit floating drug delivery system of rosiglitazone maleate: development, characterization, statistical optimization of drug release and in vivo evaluation. AAPS PharmSciTech 2009;10:887-99
- Gannu R, Bandari S, Sudke SG, Development and validation of a stability-indicating RP-HPLC method for analysis of doxofylline in human serum. Application of the method to a pharmacokinetic study. Acta Chromatogr 2007;19:149-60
- Meier J, Nuesch E, Schmidt R. Pharmacokinetic criteria for the evaluation of retard formulations. Eur J Clin Pharmacol 1974;76:429-32